Max Robotics — Global Service Robot Directory + US Certification

About

Yuelong Liang is pioneering the frontier of ingestible robotics, engineering microscopic machines that transform how we diagnose and treat gastrointestinal disorders. His work centers on two groundbreaking innovations: battery-free, tissue-adhering robotic interfaces for chronic gut electrostimulation, and gastric-retentive capsules for emergency-responsive drug delivery. Liang’s 2024 study on an ingestible, tissue-adhering robotic interface (45 citations) addresses critical limitations in current ingestible electronics—poor electrode-tissue contact, limited dwell time, and battery dependency—by introducing a device that adheres directly to gut tissue for non-invasive, long-term electrostimulation. His 2025 follow-up (6 citations) tackles emergency medicine’s Achilles’ heel: the inability to store and rapidly deploy oral medications. By developing a gastric-retentive robotic capsule that can remain in the stomach for extended periods and release drugs on demand, Liang’s work offers a paradigm shift for treating acute conditions like overdoses or allergic reactions. These contributions position him at the vanguard of bio-integrated robotics, where his devices promise to make chronic disease management less invasive and emergency care more responsive.